Re: Two Phase 2 Trials of the Novel Akt Inhibitor Perifosine in Patients with Advanced Renal Cell Carcinoma After Progression on Vascular Endothelial Growth Factor-Targeted Therapy

✍ Scribed by Taneja, Samir S.

• Book ID: 119308383
• Publisher: Lippincott Williams and Wilkins
• Year: 2012
• Tongue: English
• Weight: 104 KB
• Volume: 188
• Category: Article
• ISSN: 0022-5347
• DOI: 10.1016/j.juro.2012.08.168